General Cannabis Corp sell Medvey
Start price
22.07.23
/
95%
€0.071
Target price
22.07.24
€0.070
Performance (%)
38.73%
Price
06.09.23
€0.099
Summary
This prediction is currently active. The price for General Cannabis Corp has massively increased, which is bad news for the SELL prediction by Medvey. This prediction currently runs until 22.07.24. The prediction end date can be changed by Medvey at any time. Medvey has 95% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| General Cannabis Corp | - | - |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
According to Medvey what are the pros and cons of General Cannabis Corp for the foreseeable future?
Pros
Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Cons
Comments by Medvey for this prediction
In the thread General Cannabis Corp diskutieren
Sell mit Kursziel 0,07
Stopped prediction by Medvey for General Cannabis Corp
General Cannabis Corp
Start price
Target price
Perf. (%)
€0.16
08.12.22
08.12.22
€0.10
08.12.23
08.12.23
-54.49%
22.07.23
22.07.23
Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
General Cannabis Corp
Start price
Target price
Perf. (%)
€0.35
13.11.21
13.11.21
€2.00
13.11.22
13.11.22
-47.91%
14.11.22
14.11.22
Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
General Cannabis Corp
Start price
Target price
Perf. (%)
€0.59
04.02.20
04.02.20
€0.70
04.11.21
04.11.21
-38.81%
05.11.21
05.11.21
Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year